Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |